Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of most common and deadliest malignancies. Celastrol (Cel), a natural product derived from the Tripterygium wilfordii plant, has been extensively researched for its potential effectiveness in fighting cancer. However, its clinical application has been hindered b...
Saved in:
Main Authors: | Piao Luo (Author), Qian Zhang (Author), Shuo Shen (Author), Yehai An (Author), Lixia Yuan (Author), Yin-Kwan Wong (Author), Sizhe Huang (Author), Shaohui Huang (Author), Jingnan Huang (Author), Guangqing Cheng (Author), Jiahang Tian (Author), Yu Chen (Author), Xiaoyong Zhang (Author), Weiguang Li (Author), Songqi He (Author), Jigang Wang (Author), Qingfeng Du (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1
by: Piao Luo, et al.
Published: (2022) -
Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis
by: Cai B, et al.
Published: (2024) -
Inhibition of VDAC1 Rescues Aβ1-42-Induced Mitochondrial Dysfunction and Ferroptosis via Activation of AMPK and Wnt/β-Catenin Pathways
by: Xinpei Zhou, et al.
Published: (2023) -
Synthesis and characterisation of celastrol derivatives as potential anticancer agents
by: Hong-Jian Zhang, et al.
Published: (2018) -
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
by: Junjun Ling, et al.
Published: (2022)